Efficient and Scalable Methods for Synthesis of Midazolam Drug with an Annulation Process

Document Type : Research Article

Authors

1 Imam HussDepartment of Chemistry, Faculty of Science, University of Imam Hossein, Tehran, I.R. IRANein University

2 Department of Chemistry, Faculty of Science, University of Imam Hossein, Tehran, I.R. IRAN

Abstract

The reported methods for the synthesis of midazolam include a number of disadvantages, such as high production costs and low yields. The purpose of this investigation was to develop a more economical and technically feasible route to the synthesis of midazolam. In this research, two easy and scalable synthetic methods for the production of midazolam drugs are presented. One-pot condensation of imidoyl chloride or 1,4-benzodiazepinic N-nitrosoamidines with carbanion of two isocyanide reagents is described and two important and key tricyclic ring intermediates are synthesized. These imidazole-type structures can be derivatives by the alkylation of the imidazole ring with tert-butyl magnesium chloride at 0 °C in excellent yield, which has not been described for these intermediates in the literature. 

Keywords

Main Subjects

References

[1] Möhler H., Okada T., Benzodiazepine Receptor: Demonstration in the Central Nervous System, Science, 198: 849 (1977).
[2] Pozo del., Macias A., Alonso E., Gonzalez J., Reactions of 1,4-Benzodiazepinic N-nitrosoamidines with Tosyl methyl Isocyanide: A Novel Synthesis of Midazolam, Synthesis, 16: 2697-2703 (2004).
[3] Yang J., Teng Y., Ara S., Rallapalli S., Cook M., An Improved Process for the Synthesis of 4H-Imidazo[1,5-a][1,4]benzodiazepines, Synthesis, 40: 145687 (2009).
[4] Johnson N., Rostami-Hodjegan A., Goddard M., Tanner S., Tucker T., Contribution of Midazolam and its 1-hydroxy Metabolite to Preoperative Sedation in Children: A Pharmacokinetic-Pharmacodynamic Analysis, British Journal of Anaesthesi., 89: 428-437 (2002).
[5] Brigo F., Nardone R., Tezzon F., Trinka E., Nonintravenous Midazolam Versus Intravenous or Rectal Diazepam for the Treatment of Early Status Epilepticus: A Systematic Review with Meta-Analysis, Epilepsy & Behavior, 49: 325-336 (2015).
[6] Walser. A., Quinazolines and 1,4-benzodiazepines. 84. Synthesis and Reactions of Imidazo[1,5-a][1,4] benzodiazepines, J. Org. Chem, 43: 936 (1978).
[7] Field G.F., 2-[[2-Methyl-1-[2-benzoyl(or benzyl)phenyl]-1H-imidazol-5-yl]methyl]-1H-isoindole-1,3(2H)-diones, US Patent 4194049 (1980).
[8] Huber J. E., Process to Produce Midazolam, US Patent 5831089 (1998).
[9] Krivonos S., Sery Y., Process for Producing Highly Pure Midazolam and Salts Thereof, US Patent 7776852 (2010).
[10] Walser A, 1,2,5-Oxadiazino[5,4-a][1,4]benzodiazepine Derivatives, US Patent 4226771 (1980).
[11] Zhang Y., Woo P.W.K., Hartman J., Colbry N., Huang Y., Huang C.C., Synthesis of Carbon‐14 Labelled Midazolam, Tetrahedron Lett, 46: 2087 (2005).
[12] Hester J. B., Rudzik A. B., Kamdar B. V., Synthesis of Some New Substituted Triazolo [4,3-a][1,4] Benzodiazepine Derivatives as Potent Anticonvulsants, J. Med. Chem, 14: 1078 (1971).
[13] El-Sayed A. M., Abdel-Ghany H., El-Saghier A. M. M., Amorphous Mesoporous Iron Aluminophosphate Catalyst for the Synthesis of 1,5-Benzodiazepines, Synth. Commun. 29: 3561 (1999).
[14] Fustero S., González J., Del Pozo C., 1,4-Benzodiazepine N-Nitrosoamidines: Useful Intermediates in the Synthesis of Tricyclic Benzodiazepines,  Molecules, 11: 583 (2006).
[15] Ning R.Y., Fryer R. I., Madan P. B., Sluboski B. C., Quinazolines and 1,4-benzodiazepines. 74. Phosphorylation of ambident anions. Preparation of Some di-4-morpholinylphosphinyloxy Imines via O-Phosphorylation of Anions of Lactams, J. Org. Chem, 41: 2724 (1976).
[16] Krivonos S., Sery Y., Process for Producing Highly Pure Midazolam and Salts Thereof, US Patent 7776852 (2010).
[17] Cook J. M., Huang Q., He X., Li X., Yu J., Han D., Lelas S., McElroy J. F., Anxiolytic Agents with Reduced Sedative and Ataxic Effects, US Patent 7119196 (2006).
[18] He X., Li X., Yu J., Han D., Cook J., Huang Q., Anxiolytic Agents with Reduced Sedative and Ataxic Effects, US Patent 11/767515 (2007).
[19] Broggini G., Orlandi M., Turconi A., Zoni C., A New Synthesis of Flumazeel, Org. Prep. Proced. Int, 35: 609 (2003).
[20] Donohue S. R., Dannals R. F., A Concise and Efficient Synthesis of Flumazenil and Its Precursor for Radiolabeling with Fluorine-18, Tetrahedron Lett. 50: 7271 (2009).
[21] Walser A., Synthesis of Imidazo[1,5-a]diazepine-3-carboxylates, US Patent 4118386 (1978).
[22] Lee B. C., Moon B. S., Kim J. S., Method for Preparation of Fluorine-18-Labeled Flumazenil Using Diaryliodonium Salt Precursor, US Patent 8895727 (2014).
[23] Watjen F., Baker R., Engelstoff M., Herbert R., MacLeod A., Knight A., Merchant K., Moseley J., Saunders J., Novel Benzodiazepine Receptor Partial Agonists: Oxadiazolylimidazobenzodiazepines, J. Med. Chem. 32: 2282 (1989).
[24] Zhang Y., Woo P. W., Hartman J., Colbry N., Huang Y., Huang C. C., Convergent Syntheses of Carbon-13 Labeled Midazolam and 1′-hydroxymidazolam, Tetrahedron Letters, 46: 2087-2091 (2005). 
[25] Cook J. M., Han D., Clayton T., Gabaergic Agents to Treat Memory Deficits, US Patent 7595395 (2009).
[26] Fustero S., González J., Del Pozo C., 1,4-Benzodiazepine N-Nitrosoamidines: Useful Intermediates in the Synthesis of Tricyclic Benzodiazepines, Molecules, 11: 583-588 (2006).
[27] Blažević N., Kajfež F., A New Ring Closure Synthesis of 1,4‐benzodiazepines, J. Heterocycl. Chem, 8: 845 (1971).
[28] Nájera C., Yus M., Desulfonylation Reactions: Recent Developments, Tetrahedron, 55: 10547-10658 (1999).
[29] Gilman N. W., Rosen P., Earley J. V., Cook C. M., Blount J. F., Todaro L. J., Atropisomers of 1,4-benzodiazepines Synthesis and Resolution of Imidazo[1,5-a][1,4]benzodiazepines, J. O. C., 58: 3285-3298 (1993).
[30] Cook J.M., Huang Q., Huang S., Sarma P.S., Zhang C., Stereospecific Anxiolytic and Anticonvulsant Agents with Reduced Muscle-Relaxant, Sedative-Hypnotic and Ataxic Effects, U.S. Patent No. 7,618,958 (2009). 
[31] Cook M., Huang Q., He X., Li X., Yu J., Han D., McElroy J. F., Anxiolytic Agents with Reduced Sedative and Ataxic Effects, U.S. Patent No. 7,119,196 (2006).
[32] Zhang P., Zhang W., Liu R., Harris B., Skolnick P., CookJ. M., Synthesis of Novel Imidazobenzodiazepines as Probes of the Pharmacophore for "Diazepam-Insensitive" GABAA Receptors, J. Med. Chem, 38; 1679 (1995).
[33] Cook J. M., Huang Q., He X., Li X., Yu J., Han D., Lelas S., McElroy J. F., Anxiolytic Agents with Reduced Sedative and Ataxic Effects, US Patent 7119196 (2006).
[34] Kyungjin K., Volkman S. K., Ellman J. A., Synthesis of 3-Substituted 1,4-Benzodiazepin-2-ones, J. Braz. Chem. Soc, 9: 375 (1998).
[35] Cepanec I., Litvić M., Pogorelić I., Efficient Synthesis of 3-Hydroxy-1,4-benzodiazepines Oxazepam and Lorazepam by New Acetoxylation Reaction of 3-Position of 1,4-Benzodiazepine Ring, Org. Process Res. Dev, 10: 1192 (2006).
[36] Cheng P., Zhang Q., Ma Y. B., Jiang Z. Y., Zhang X. M., Zhang F. X., Chen J. J., Synthesis and in Vitro anti-hepatitis B virus activities of 4-aryl-6-chloro-quinolin-2-one and 5-aryl-7-chloro-1,4-benzodiazepine derivatives, Bioorg. Med. Chem. Lett, 18; 3787 (2008).
[37] Hannoun M., Žinić M., Kolbah D., Kajfež F., BlaŽević N., Synthesis of imidazolidin‐4‐ones and Their Conversion into 1,4‐benzodiazepin‐2‐ones, J. Heterocycl. Chem, 18: 963 (1981).
[38] Massah A. R., Gharaghani S., Lordejani H. A., Asakere N., New And Mild Method for the Synthesis of Alprazolam and Diazepam and Computational Study of Their Binding Mode to GABAA Receptor, Medicinal Chemistry Research 25: 1538-1550 (2016).
[39] He X., Li X., Yu J., Han D., Cook J., Huang Q., Anxiolytic Agents with Reduced Sedative and Ataxic Effects, US Patent 11/767515 (2007).
[40] Sternbach L. H., 1,4‐Benzodiazepines Chemistry and Some Aspects of the Structure‐Activity Relationship, Angew. Chem. Int. Ed. Engl, 10: 34 (1971).
[41] Zhang Y., Woo P. W., Hartman J., Colbry N., Huang Y., Huang C. C., Convergent Syntheses of Carbon-13 Labeled Midazolam and 1′-hydroxymidazolam, Tetrahedron Lett. 46: 2087 (2005).
[42] Sati B., Sati H., Saklani S., Bhatt P.C., Mishra R., Synthesis of The Impurities During the Manufacture of Bulk Drug Midazolam and Separation of These Impurities by HPLC, Acta. Pharm, 63: 385 (2013).
[43] Fustero S., González J., Del Pozo C., 1,4-Benzodiazepine N-Nitrosoamidines: Useful Intermediates in the Synthesis of Tricyclic Benzodiazepines, Molecules, 11: 583 (2006).
[44] Taghizadeh M.J., Malakpouri G.R., Javidan A., Improved And Scalable Methods for the Synthesis of Midazolam Drug and its Analogues Using Isocyanide Reagents, Journal of the Iranian Chemical Society, 16: 785–794 (2019).
[45] Walser A., Benjamin L., Flynn T., Mason C., Schwartz R., Fryer R., Quinazolines and 1,4-Benzodiazepines. 84. Synthesis and Reactions of imidazo[1,5-a][1,4]benzodiazepines, J. Org. Chem, 43: 936 (1978).
[46] Bock M.G., Di Pardo R.M., Evans B.E., Rittle K.E., Veber D.F., Freidinger R. M., Hirshfield J., Synthesis and Resolution of 3-amino-1,3-dihydro-5-phenyl-2H-1,4-benzodiazepin-2-ones, J. Org. Chem, 52: 3232 (1987).
[47] Gu Z. Q., Wong G., Dominguez C., de Costa B. R., Rice K. C., Skolnick P., Synthesis and Evaluation of Imidazo[1,5-a][1,4]benzodiazepine Esters with High Affinities and Selectivities at "Diazepam-Insensitive" Benzodiazepine Receptors, J. Med. Chem, 36: 1001 (1993).
[48] Fustero S., González J., Pozo C. Del., 1,4-Benzodiazepine N-Nitrosoamidines: Useful Intermediates in the Synthesis of Tricyclic Benzodiazepines, Molecules, 11: 583 (2006).
[49] Rogers-Evans M., Spurr P., Hennig M., The Isolation and Use of A Benzodiazepine Iminochloride for the Efficient Construction of Flumazenil, Tetrahedron Lett, 44: 2425 (2003).
[50] Rogers-Evans M., Spurr P., Process for the Manufacture of Imidazodiazepine Derivatives, US Patent 5670640 (1997).
[51] Walser A., Guidotti A., Costa E., Benzodiazepines and Compositions for Treating Anxiety and Panic Disorders, and Idiopathic and Psychomotor Epilepsy, US Patent 5317018 (1994).

Files

Share

How to cite

Statistics